Adriana Lages
University of Coimbra
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Adriana Lages.
Frontiers in Endocrinology | 2018
Alexandre Rebelo-Marques; Adriana Lages; Renato Andrade; Carlos Ribeiro; Anabela Mota-Pinto; Francisco Carrilho; João Espregueira-Mendes
World population has been continuously increasing and progressively aging. Aging is characterized by a complex and intraindividual process associated with nine major cellular and molecular hallmarks, namely, genomic instability, telomere attrition, epigenetic alterations, a loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. This review exposes the positive antiaging impact of physical exercise at the cellular level, highlighting its specific role in attenuating the aging effects of each hallmark. Exercise should be seen as a polypill, which improves the health-related quality of life and functional capabilities while mitigating physiological changes and comorbidities associated with aging. To achieve a framework of effective physical exercise interventions on aging, further research on its benefits and the most effective strategies is encouraged.
Endocrinology, Diabetes & Metabolism Case Reports | 2018
Diana Oliveira; Adriana Lages; Sandra Paiva; Francisco Carrilho
Summary Addison’s disease, or primary adrenocortical insufficiency, is a long-term, potentially severe, rare endocrine disorder. In pregnancy, it is even rarer. We report the case of a 30-year-old pregnant patient with Addison’s disease, referred to Obstetrics-Endocrinology specialty consult at 14 weeks gestation. She had been to the emergency department of her local hospital various times during the first trimester presenting with a clinical scenario suggestive of glucocorticoid under-replacement (nausea, persistent vomiting and hypotension), but this was interpreted as normal pregnancy symptoms. Hydrocortisone dose was adjusted, and the patient maintained regular follow-up. No complications were reported for the remainder of gestation and delivery. Pregnant patients with Addison’s disease should be monitored during gestation and in the peripartum period by multidisciplinary teams. Adjustments in glucocorticoid and mineralocorticoid replacement therapy are often necessary, and monitoring should be based mainly on clinical findings, which becomes increasingly difficult during pregnancy. Patient education and specialized monitoring are key to avoiding complications from under- or over-replacement therapy in this period. Learning points: An increase in glucocorticoid replacement dose is expected to be necessary during pregnancy in a woman with Addison’s disease. Patient education regarding steroid cover and symptoms of acute adrenal crisis are fundamental. Monitoring in this period is challenging and remains mainly clinical. The increase in hydrocortisone dose often obviates the need to increase fludrocortisone dose.
Case Reports | 2016
Adriana Lages; Margarida Bastos; Patrícia Oliveira; Francisco Carrilho
Although it is a rare entity, primary lymphoma of the adrenal gland should be considered in the differential diagnosis of bilateral nodular adrenal lesions, particularly when there is evidence of associated adrenal insufficiency. We describe the case of an 83-year-old woman admitted to the emergency department due to a months history of asthenia, weight loss, anorexia and nausea. Abdominopelvic CT showed bilateral nodular lesions of adrenal glands and a stimulation test with tetracosactide was compatible with primary adrenal insufficiency. CT-guided biopsy of the left adrenal gland was performed, and histopathological results were consistent with diffuse large B-cell lymphoma. Positron emission tomography 18F-fluorodeoxyglucose detected two intensely hypermetabolic lesions limited to both adrenal glands. Replacement therapy with hydrocortisone 15 mg/day and fludrocortisone 0.1 mg/day was promptly started and chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone was initiated after haematology-oncology consultation.
Revista de Medicina Desportiva informa | 2018
Adriana Lages; Centro Hospitalar e Universitário de Coimbra; Alexandre Rebelo-Marques; Francisco Carrilho
Endocrine Abstracts | 2018
Lucia Fadiga; Joana Saraiva; Diana Oliveira; Adriana Lages; Mara Ventura; Nelson Cunha; Diana Catarino; Joana Guiomar; Diana Silva; Carolina Moreno; Francisco Carrilho
Endocrine Abstracts | 2018
Mara Ventura; Isabel Paiva; Miguel Melo; Adriana Lages; Diana Oliveira; Diana Martins; Nelson Cunha; Lucia Fadiga; Diana Catarino; Francisco Carrilho
Endocrine Abstracts | 2018
Diana Catarino; Cristina Ribeiro; Diana Oliveira; Diana Martins; Adriana Lages; Mara Ventura; Nelson Cunha; Lucia Fadiga; Bernardo Marques; Francisco Carrilho
Endocrine Abstracts | 2018
Adriana Lages; Isabel Paiva; Luis Cardoso; Patrícia Oliveira; Dircea Rodrigues; Carolina Moreno; Diana Martins; Diana Oliveira; Mara Ventura; Nelson Cunha; Bernardo Marques; Diana Catarino; Lucia Fadiga; Francisco Carrilho
Endocrine Abstracts | 2018
Bernardo Marques; Margarida Bastos; Diana Oliveira; Diana Martins; Adriana Lages; Mara Ventura; Nelson Cunha; Lucia Fadiga; Diana Catarino; Francisco Carrilho
Endocrine Abstracts | 2018
Bernardo Marques; Diana Oliveira; Mara Ventura; Adriana Lages; Nelson Cunha; Diana Catarino; Lucia Fadiga; Margarida Bastos; Sandra Paiva; Isabel Paiva; Leonor Gomes; Francisco Carrilho